Our Blog
Read our latest articles and grow your knowledge.

Gene Therapy Evidence, Not Injections: Follistatin 344 for Researchers
Explains why the strongest evidence for follistatin 344 comes from single dose AAV gene therapy, not injected protein. Covers safety monitoring, analytic…

Avoid False Positives, Missed LPS: Endotoxin Testing for Peptide Labs
Practical rules for peptide labs: use LAL or rFC, calculate MVD, validate I/E recovery (50–200%), and verify lot matched COAs before assays.

4–5 Half Lives to Set Dosing: Peptide Half Life for Labs
Lab-focused peptide half life guide with a sourced quick reference chart, assay and storage rules, plus dosing math using 4–5 half lives to time dosing.

Let Stability Data Decide Cold Chain Shipping for Research Labs
Practical cold chain shipping for peptide research labs. Use batch stability to set temperature bands, size packouts to worst case lanes, and lock SOPs…

500–1,000 mg/day Evidence: Urolithin A Research for Investigators
Researcher synthesis of urolithin A trials: four week biomarker shifts, 500–1,000 mg/day dosing, protocol and sourcing tips.

28 Amino Acid Thymosin Alpha 1 for Labs: FDA Ruling and COA Steps
Research review of thymosin alpha 1: mechanism, hepatitis and sepsis evidence, the FDA ruling, and COA, storage and sourcing guidance for labs.

Aseptic Technique for Clinicians & Students: Verify Sterility with SOPs
Practical aseptic technique for clinicians and lab students: name key parts, verify sterility, and follow SOP-ready workflows to prevent contamination at…

FDA Accelerated Approval Sept 2026: Elamipretide Peptide, XLMS for Labs
For researchers and labs: a concise review of the elamipretide peptide covering FDA accelerated approval Sept 2025 for Barth syndrome (patients ≥30 kg),…

Phase 2b Failure in 536 Subjects: AOD-9604 Peptide Evidence for Labs
Researcher guide to AOD-9604: why a 12 week 2.6 kg signal failed the 24 week Phase 2b in 536 subjects, and how to verify lab COAs for research-grade peptide.